Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #285765 on Anavex Life Sciences Corp (AVXL)
rayovacAAA
12/01/20 3:57 PM
#285771 RE: XenaLives #285765
Rather odd that experts like Hampel, Kaufmann and Aarsland have been taken in by this so-called "fraud".
Eisai unveiled the transfer of Irizarry to the new role alongside news of the appointment of Harald Hampel as VP, global medical affairs, Alzheimer's. The appointment puts Hampel in charge of coming up with Eisai’s global medical strategies in Alzheimer's and dementia. And he'll oversee phase 3b and 4 clinical trials of Alzheimer’s drugs, if one makes it that far.